The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas

por Seguin, F, Carvalho, M A, Bastos, D C, Agostini, M, Zecchin, K G, Alvarez-Flores, M P, Chudzinski-Tavassi, A M, Coletta, R D, Graner, E
Publicado 2012